Laura M. Calvi

Osteoblastic activation in the hematopoietic stem cell niche.

When is it appropriate to order an ionized calcium?

Elucidating bone marrow edema and myelopoiesis in murine arthritis using contrast-enhanced magnetic resonance imaging.

Osteoblastic expansion induced by parathyroid hormone receptor signaling in murine osteocytes is not sufficient to increase hematopoietic stem cells.

PTH-enhanced structural allograft healing is associated with decreased angiopoietin-2-mediated arteriogenesis, mast cell accumulation, and fibrosis.

Cellular complexity of the bone marrow hematopoietic stem cell niche.

Osteolineage cells and regulation of the hematopoietic stem cell.

Hematopoietic stem cell cultures and assays.

Notch signaling in the malignant bone marrow microenvironment: implications for a niche-based model of oncogenesis.

Residual Disease in a Novel Xenograft Model of RUNX1-Mutated, Cytogenetically Normal Acute Myeloid Leukemia.

Geographic variation in cost of care for pituitary tumor surgery.

The aging hematopoietic stem cell niche: Phenotypic and functional changes and mechanisms that contribute to hematopoietic aging.

The Notch Ligand Jagged1 Regulates the Osteoblastic Lineage by Maintaining the Osteoprogenitor Pool.

The microenvironment in myelodysplastic syndromes: Niche-mediated disease initiation and progression.

Impact of aging on bone, marrow and their interactions.

EVI1 overexpression reprograms hematopoiesis via upregulation of Spi1 transcription.

Aged marrow macrophages expand platelet-biased hematopoietic stem cells via Interleukin1B.

Flaming and fanning: The Spectrum of inflammatory influences in myelodysplastic syndromes.

Acute and late effects of combined internal and external radiation exposures on the hematopoietic system.

What is the role of the microenvironment in MDS?

Improved in vivo Experimental Screening Identifies an Anabolic Analog of 1,25 Dihydroxyvitamin D3 With Minimal Bone Resorption Activity.

Reduction of leukemic burden via bone-targeted nanoparticle delivery of an inhibitor of C-chemokine (C-C motif) ligand 3 (CCL3) signaling.

CCR5 maintains macrophages in the bone marrow and drives hematopoietic failure in a mouse model of severe aplastic anemia.

GM-CSF drives myelopoiesis, recruitment and polarisation of tumour-associated macrophages in cholangiocarcinoma and systemic blockade facilitates antitumour immunity.

The roles of bone remodeling in normal hematopoiesis and age-related hematological malignancies.

Vitamin D Receptor Antagonist MeTC7 Inhibits PD-L1.

Efferocytosis by bone marrow mesenchymal stromal cells disrupts osteoblastic differentiation via mitochondrial remodeling.